Xilio Therapeutics XLO
NASDAQ XLO
$8.35 -0.05 (-0.65%)
As of: Oct 22, 2026 · 11:12 AM EDT

Xilio Therapeutics (XLO) EV to FCF (2025)

Updated

Xilio Therapeutics' (XLO) EV to FCF stood at -1.66 in Q1 2025.

Analysis

Xilio Therapeutics (XLO) EV to FCF (2025) Analysis & Trends

On a TTM basis, Xilio Therapeutics' EV to FCF came in at -10.75 as of Mar 31, 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn
10 Xilio Therapeutics 161.93 Mn -365.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -1.66
API Access

Xilio Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=XLO&period=max&api_key=YOUR_API_KEY